CHICAGO--(BUSINESS WIRE)--ASCO Abstract Number: 6522. An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II clinical trial, say researchers at Mayo Clinic.
